// App-Quantinova.ai

e15087 : Mapping PD-1 inhibitors side effects using patient-reported outcomes (PRO) generated by a digital patient-powered network (PPN).

Researchers

Presenter

  • Daniel A. Vorobiof

Principal Investigators

  • Irad Deutsch

  • Eliran Malki

  • Maytal Bivas-Benita

Medical Centers

  • Sandton Oncology Centre, Johannesburg, South Africa

  • BelongTail LTD, Tel-Aviv, Israel

Locations

  • South Africa

  • Israel

Companies

  • BelongTail LTD

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Programmed cell death protein 1

Drug/Treatment

  • Pembrolizumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved